Covishield

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

Interval between second COVID vaccine, booster dose to remain 6 months

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

Interval between second COVID vaccine, booster dose to remain 6 months

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

Hospitals sceptical of getting fresh stocks for boosters amid demand concerns

opoyicentral
Opoyi Central

. Mumbai, Maharashtra, India

Covishield, Covaxin prices slashed to Rs 225 for private hospitals

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

DCGI grants conditional market approval for Covishield, Covaxin

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

DGCI panel askes Bharat Biotech to conduct phase 3 trial of intranasal vaccine

opoyicentral
Opoyi Central

. Pune, Maharashtra, India

Serum Institute of India has applied for full Covishield approval: Adar Poonawalla

opoyicentral
Opoyi Central

. Hyderabad, Telangana, India

Indias indigenous Corbevax Coronavirus Vaccine: All you need to know

opoyicentral
Opoyi Central

. Delhi, India

Gap between 2nd dose and ‘precautionary booster’ to be 9-12 months: Report

opoyicentral
Opoyi Central

. New Delhi, Delhi, India

ICMR advises against booster shot for omicron variant in India